Navigation Links
Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
Date:2/14/2008

fiscal 2008," said Chairman and CEO, Mr. Qingtai Liu. "Our revenues and net income kept growing dramatically during this quarter due to higher glucose product prices, increased cornstarch production and sales, improved sales of higher value products and the benefits from our vertically integrated production line. We believe that through manufacturing innovative products to meet market demand, we would be able to command better profit margins, diversify our product lines and minimize our operating risks."

Gross profit for the three months ended December 31, 2007 was $5.9 million, an increase of 91% from $3.1 million for the same period of the prior year. Gross margin for the second quarter of fiscal 2008 was 23.5%. The increased gross profit was mostly due to economies of scale resulting from the expansion of production output and enhanced operating efficiencies. Although product cost increased as a result of commodity price increases and other raw material price increases, the selling price was higher than the price increase of raw materials, thus making its gross profit higher.

Selling, general and administrative expenses for the three months ended December 31, 2007 were $1.8 million, an increase of $0.9 million, or 89.4% compared with the corresponding period in 2006. The increase in selling, general and administrative expenses was the result of the increase of our production output, expansion of the Company's domestic sales network and increased shipping costs due to higher sales of cornstarch.

Shengtai Pharmaceutical's operating income in the three months ended December 31, 2007 increased 121.2% to $4.1 million from $1.8 million in the prior year, while the operating margin increased to 16.2% from 14.9%.

Net income for the three months ended December 31, 2007 was $3.1 million, an increase of $1.5 million, or 97% compared with the corresponding period in 2006. The increase in net income was due to an increase in our product prices, sa
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
2. Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
3. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
4. Shengtai Pharmaceutical, Inc. to Present at Roth Conference
5. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
6. BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
9. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynchs Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... Hospital reached a medical milestone April 3, performing ... novel way to access the heart. , Henry ... States performing the unique procedure called transcaval valve ... major blood vessels. , Northern Michigan resident Viola ... on July 3, 2013 when traditional valve replacement ...
(Date:4/14/2014)... that moderate to severe obstructive sleep apnea is independently ... death. , Results of the 20-year follow-up study show ... were four times more likely to die (hazard ratio ... a stroke (HR = 3.7), three times more likely ... times more likely to develop cancer. Results were adjusted ...
(Date:4/14/2014)... DALLAS April 14, 2014 Popular web information ... people to read and doesn,t address the appropriate risks ... Southwestern Medical Center gastroenterologists suggests. , In a review ... patient education materials for colorectal cancer screening were written ... the sites failed to address key risks, as well ...
(Date:4/14/2014)... new study identifies a molecule that is a probable ... molecule could be an important target for colorectal cancer ... The study of microRNA-135b (miR-135b) in two animal models ... Cancer Cell and was led by researchers at ... G. James Cancer Hospital and Richard J. Solove Research ...
(Date:4/14/2014)... unearthed still more evidence that antibiotics can contribute ... in the journal Antimicrobial Agents and Chemotherapy ... gained weight and had significant changes in their ... Didier Raoult, of Aix-Marseille University, Marseille, France, followed ... doxycycline and hydroxychloroquine for Q fever, and 34 ...
Breaking Medicine News(10 mins):Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Study identifies a likely key driver of colorectal cancer development and progression 2Health News:Long-term antibiotic treatment for Q fever causes weight gain 2
... study from the Massachusetts General Hospital (MGH) supports previous ... risk for smoking and substance abuse. The article ... describing the largest such investigation to date and the ... that bipolar-associated risk is independent of the risk conferred ...
... are the first to identify two proteins responsible for ... long known that plant cells respond to physical forces. ... response remained a mystery. , As the name ... that respond to mechanical forces such as gravity, pressure, ...
... LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider of ... today upcoming investment community events., On Tuesday, ... and,Chief Financial Officer, Alan Buckey, will participate in ... Access Conference in New York., On Wednesday, ...
... Safety Tips Prevent Lawn Mower Injuries ... June is National Safety Month, CHICAGO, ... bike helmets, knee pads, and sun block.,However, during the summer months, ... a bike and can be dangerous if proper safety,precautions are not ...
... In autoimmune diseases, the immune system turns against the ... for no apparent reason. Partly because the origins of ... and the suffering they inflict is enormous. Now Weizmann ... future may make it possible to treat autoimmune diseases ...
... Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced ... were highlighted during the American,Society of Clinical Oncology ... that supports the continuation of clinical,development, and both ... doses.,Results from Eli Lilly,s Phase 1 clinical trial ...
Cached Medicine News:Health News:Report confirms increased risk of smoking, substance abuse in bipolar adolescents 2Health News:Researchers identify proteins making up mechanosensitive ion channels 2Health News:Researchers identify proteins making up mechanosensitive ion channels 3Health News:More Than Sun Block Required to Protect Kids While Mowing Lawns 2Health News:More Than Sun Block Required to Protect Kids While Mowing Lawns 3Health News:More Than Sun Block Required to Protect Kids While Mowing Lawns 4Health News:Weizmann Institute scientists develop a new approach to treating autoimmune disease 2Health News:Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology 2Health News:Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology 3Health News:Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology 4
(Date:1/14/2014)... 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th ... Miami Beach Convention Center from January 21-24. ... More than 3,500 attendees from top pharmaceutical, fine chemical ... conference, which includes on-site education sessions, daily networking events ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ... need for oxygen when air is thin," states Dr Barnes. She ...
(Date:1/14/2014)... , January 14, 2014 ... leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, ... year-over-year sales growth for the fourth straight ... reduce the risk of exposure for pharmacy ... who prepare and administer hazardous drugs, such ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: